IBanga le-25316-40-9 le-Doxorubicin Hydrochloride ye-High Purity ye-Pharmaceutical kuNyango loMhlaza
Imvelisoigama | Doxorubicin Hydrochloride |
Izithethantonye | (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl) oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy -8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride |
Inombolo yeCAS. | 25316-40-9 |
Imbonakalo | I-Orenji-ebomvu okanye i-crystalline powder ebomvu |
Ifomula yeemolekyuli | C27H29NO11.HCl |
Ubunzima beMolekyuli | 579.99 |
Ukusetyenziswa | Ibakala leyeza okanye injongo yophando |
Ukupakisha | Ngokwesicelo sakho |
Ugcino | Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo |
Igama leMveliso: Doxorubicin Hydrochloride Inombolo yeCAS:25316-40-9 | ||
IZINTO | IMIGANGATHO | IZIPHUMO |
Imbonakalo | I-Orange-ebomvu okanye i-crystalline powder ebomvu;Akukho bungqina bubonakalayo bokungcoliswa zizinto zangaphandle | Iyahambelana |
Ukunyibilika | Inyibilika emanzini nakwi-methanol;inyibilika kancinane kwi-ethanol;ayinyibiliki kwiacetone. | Iyahambelana |
Ukuchongwa | A: I-IR spectrum ihambelana ne-IR spectrum yomgangatho wereferensi | Iyahambelana |
B: Ixesha lokugcinwa kwencopho ye-doxorubicin kwichromatogram yolungiselelo lwe-Assay ihambelana naleyo kwichromatogram ye Ukulungiswa okusemgangathweni, njengoko kufunyenwe kwi-Assay. | Iyahambelana | |
pH | 4.0 ukuya ku-5.5 | 4.9 |
Amanzi | Akukho ngaphezu kwe-4.0% | 2.1% |
Izinto ezinxulumeneyo | Ukungcola A (Doxorubicinone) ≤0.5% | 0.23% |
Nayiphi na enye into engaziwayo yokungcola ≤0.2% | 0.17% | |
Ukungcola okungaziwayo ngokupheleleyo ≤0.5% | 0.37% | |
Ukungcola ngokupheleleyo ≤2.0% | 0.6% | |
Izinyibilikisi ezishiyekileyo | Iacetone ≤ 0.5% IAcetone +Ethanol ≤ 2.5% imethanol ≤ 0.3% IDichloromethane ≤ 0.06% | 0.34% 1.6% 0.07% Ayifunyanwa |
Isivavanyi | 98.0% ~ 102.0% | 99.2% |
Isiphelo:Iziphumo zihambelana nomgangatho we-USP34. |